drugset / Trial / NCT00816127

Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction

NCT00816127

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate how effective and cost saving 1-deamino-8-D-arginine vasopressin (desmopressin, DDAVP) is as opposed to the transfusion of blood products in preventing bleeding after teeth extraction in persons with severe liver disease being evaluated for liver transplant.

Timeline

Start
2003-10
Primary completion
2007-05
Completion
2007-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmopressin Peptide 300 ug Intranasal